Suppr超能文献

博洛尼亚地方卫生信托机构中抗抑郁药的使用与帕金森病风险:一项历史性队列研究。

Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study.

作者信息

Zenesini Corrado, Baldin Elisa, Vignatelli Luca, Poluzzi Elisabetta, Antonazzo Ippazio, Calandra-Buonaura Giovanna, Guarino Maria, De Carolis Piero, Cortelli Pietro, D'Alessandro Roberto

机构信息

IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

出版信息

J Neurol Sci. 2019 Oct 15;405:116421. doi: 10.1016/j.jns.2019.08.006. Epub 2019 Aug 7.

Abstract

BACKGROUND

Depression is considered one of the prodromal symptoms of Parkinson's disease (PD) along with sleep disorders, hyposmia and constipation. Prodromal symptoms refer to the stage wherein early motor symptoms and signs allowing a diagnosis of PD are not yet present. The objective of this study was to investigate the association between the use of antidepressants, as indirect measure of depression, and subsequent PD onset, clinically diagnosed, in the Local Health Trust of Bologna, Italy.

METHODS

Historical cohort study with use of antidepressants as exposure and PD onset as outcome. The cohort considered consisted of inhabitants of Bologna aged ≥35 years in 2005; those who had used antidepressants in the previous 3 years were excluded. Subjects were followed up from 2006 and until PD onset, migration out of Bologna, death or end of the study period (2017), whichever came first. "The ParkLink Bologna" system was used to detect disease onset. "ParkLink Bologna" is a research study including patients with a clinical diagnosis of PD residing in Bologna. Residents that used antidepressants for at least 180 consecutive days within 1 year were considered exposed. Hazard ratios (HR) and 95% confidence interval (CI) were estimated with Cox proportional hazards models, using exposure as time-dependent variable and adjusting for potential confounders: age, gender, use of medical care and comorbidities.

RESULTS

From 2006 to 2017 199,093 person-years were exposed and 4,286,470 not exposed. Fifty-one subjects with PD were identified in the exposed group and 556 subjects in the non-exposed showing an association of adjusted HR = 1.7 (CI 1.3-2.3). The association was stronger for males (HR 2.2, CI 1.5-3.2) compared to females (HR 1.2, CI 0.8-1.9), for subjects ≤65 years of age (HR 2.4, CI 1.6-3.6) vs. >65 years (HR 1.3, CI 0.8-1.9) and for those with less comorbidities. Age and gender were confounders in the associations between antidepressant use and PD onset.

CONCLUSIONS

The use of antidepressants as indirect measure of depression is associated with the subsequent development of PD. Our findings confirm that depression may precede the onset of motor symptoms in PD. The association is stronger for younger subjects, who are males and with fewer comorbidities.

摘要

背景

抑郁症与睡眠障碍、嗅觉减退和便秘一样,被认为是帕金森病(PD)的前驱症状之一。前驱症状是指尚未出现可确诊PD的早期运动症状和体征的阶段。本研究的目的是调查在意大利博洛尼亚地方卫生信托机构中,使用抗抑郁药(作为抑郁症的间接指标)与随后临床诊断的PD发病之间的关联。

方法

采用以使用抗抑郁药为暴露因素、PD发病为结局的历史性队列研究。该队列由2005年年龄≥35岁的博洛尼亚居民组成;排除在过去3年中使用过抗抑郁药的人。对受试者从2006年开始随访,直至发生PD、迁出博洛尼亚、死亡或研究期结束(2017年),以先发生者为准。使用“博洛尼亚ParkLink”系统检测疾病发病情况。“博洛尼亚ParkLink”是一项针对居住在博洛尼亚且临床诊断为PD的患者的研究。在1年内连续使用抗抑郁药至少180天的居民被视为暴露组。使用Cox比例风险模型估计风险比(HR)和95%置信区间(CI),将暴露作为时间依赖性变量,并对潜在混杂因素进行调整:年龄、性别、医疗服务使用情况和合并症。

结果

2006年至2017年,暴露组有199,093人年,非暴露组有4,286,470人年。暴露组中有51名PD患者,非暴露组中有556名,调整后的HR = 1.7(CI 1.3 - 2.3)显示出关联。与女性(HR 1.2,CI 0.8 - 1.9)相比,男性的关联更强(HR 2.2,CI 1.5 - 3.2);≤65岁的受试者(HR 2.4,CI 1.6 - 3.6)与>65岁的受试者(HR 1.3,CI 0.8 - 1.9)相比,以及合并症较少的受试者中关联更强。年龄和性别是抗抑郁药使用与PD发病之间关联的混杂因素。

结论

使用抗抑郁药作为抑郁症的间接指标与随后PD的发生有关。我们的研究结果证实,抑郁症可能先于PD运动症状的出现。对于年轻受试者、男性受试者以及合并症较少的受试者,这种关联更强。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验